MultiBacMam
BacMam™ is an increasingly popular system that facilitates delivery of heterologous DNAs to broad range of mammalian transduction targets. BacMam uses baculovirus as a vector, and has distinct advantages over other mammalian transfection methods given the large heterologous DNA carrying capacity of baculovirus (>40kbp), the uptake of baculovirus by a broad range of mammalian cell types, and the sophisticated molecular biology technologies that have evolved over the last 20 years to support generation of baculovirus expression vectors. MultiBacMam™ is the first BacMam system designed specifically to allow modular, DNA recombination based assembly of multiexpression cassettes for multiprotein co-expression in mammalian cells. MultiBacMam™ uses the same DNA recombination technologies as MultiBac™, but with mammalian promoters, and a “mammalianized” baculovirus- displaying a VSV peptide on the baculovirus surface that increases virus uptake by an order of magnitude, and a stably integrated fluorescent protein to simplify monitoring of experiments. MultiBacMam™ transfer vectors are fully synthetic, comprising only functional DNA, and as a result are small and easy to handle. The MultiBacMam™ baculovirus genome (DH10EMBacVSV) is under continuous development to remove harmful/non-essential genes (e.g. v-cath and chiA) and DNA recombination hotspots, and contains an integrated fluorescent protein expression cassette to allow for ease of monitoring virus titer. The MultiBacMam™ virus particle displays the VSV peptide on its surface to increase efficiency of entry into mammalian cells by around 1 order of magnitude compared to prior BacMam virus systems.
Complete MultiBacMam Kit with Competent Cells
Recent Posts
-
How to Perform Qualitative and Quantitative Analysis on WB, IHC, IF, and FC Results
Introduction to Qualitative and Quantitative Analysis in WB, IHC, IF, and FC Western Blot (WB), …12th Mar 2025 -
Sargramostim (rhu GM-CSF) and Immune Checkpoint Inhibitors : Combinatorial Therapeutic Studies in Metastatic Melanoma
Metastatic melanoma presents significant treatment challenges, but advancements in immunotherapy, p …10th Mar 2025 -
FBA2025: Advancing the Frontiers of Developmental Biology with Fluorescence Assays
The FBA2025 conference, held at the Mansfield Holiday Inn in Massachusetts on March 3, 2025, was a g …5th Mar 2025